GUANGZHOU, China, April 26, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock"))), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it will change the ratio of its American depositary shares (the "ADSs") to Class A ordinary shares from one (1) ADS representing one (1) Class A ordinary share to one (1) ADS representing ten (10) Class A ordinary shares (the "ADS Ratio Cha ...

Exhibit 99.1 Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results GUANGZHOU, China, March 29, 2024—Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the "Company" or "Burning Rock"), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months and the year ended December 31, 2023. 2023 Business Overview and Recent Updates • Corporate Updates • Completed profitability-dri ...

GUANGZHOU, China, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock"))), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it has received written notification from the staff of the Listing Qualifications Department of the Nasdaq Stock Market LLC ("NASDAQ") dated December 29, 2023, indicating that for the last 30 consecutive business days, the closing bid price ...

Burning Rock Biotech Limited (NASDAQ:BNR) Q3 2023 Earnings Call Transcript November 30, 2023 7:00 AM ET Company Participants Yusheng Han - Founder, Chairman and Chief Executive Officer Leo Li - CFO Joe Zhang - CTO Conference Call Participants Operator Before we begin, I would like to remind you that this conference call contains forward-looking statements within the meaning of the Section 21E of the Securities Exchange Act of 1934 as amended and as defined in the U.S. Private Securities Litigation Reform Ac ...

Burning Rock Biotech Limited 3Q2023 results Nasdaq and LSE: BNR Disclaimer This presentation has been prepared by Burning Rock Biotech Limited (the “Company”) solely for information purpose and has not been independently verified. No representations, warranties or undertakings, express or implied, are made by the Company or any of its affiliates, advisers, or representatives as to, and no reliance should be placed upon, the accuracy, fairness, completeness or correctness of the information or opinions prese ...

Exhibit 99.1 Burning Rock Reports Third Quarter 2023 Financial Results GUANGZHOU, China, November 30, 2023—Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the "Company" or "Burning Rock"), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended September 30, 2023. Recent Business Updates • Therapy Selection and Minimal Residual Disease (MRD) • Personalized Minimal Residual Dise ...

Exhibit 99.1 Burning Rock Reports Second Quarter 2023 Financial Results GUANGZHOU, China, August 31, 2023—Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the "Company" or "Burning Rock"), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended June 30, 2023. Recent Business Updates • Therapy Selection and Minimal Residual Disease (MRD) • Presented study results on extensive-sta ...

Burning Rock Biotech Limited (NASDAQ:BNR) Q2 2023 Earnings Conference Call August 31, 2023 8:00 AM ET Company Participants Yusheng Han - Founder, Chairman and CEO Leo Li - CFO Conference Call Participants Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to Burning Rock's 2023 Second Quarter Earnings Conference Call. [Operator Instructions] Please note that today's conference is being recorded. Before we begin, I'd like to remind you that this conference call contains forward-l ...

Burning Rock Biotech Limited 1Q2023 results Nasdaq and LSE: BNR 30 May 2023 Disclaimer This presentation has been prepared by Burning Rock Biotech Limited (the "Company") solely for information purpose and has not been independently verified. No representations, warranties or undertakings, express or implied, are made by the Company or any of its affiliates, advisers, or representatives as to, and no reliance should be placed upon, the accuracy, fairness, completeness or correctness of the information or op ...

Burning Rock Biotech Limited (NASDAQ:BNR) Q1 2023 Earnings Conference Call May 30, 2023 8:00 AM ET Company Participants Yusheng Han - Founder, Chairman & CEO Leo Li - CFO Joe Zhang - CTO Conference Call Participants Alexis Yan - Morgan Stanley Operator Good day, and thank you, for standing by. Welcome to the Burning Rock’s 2023 Q1 Earnings Conference Call. Before we begin, I’d like to remind you that this conference call contains forward-looking statements within the meaning of Section 21(e) of the Securiti ...